OR WAIT null SECS
December 11, 2014
US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.
December 04, 2014
No evidence that Fluad vaccine caused deaths in Italy, says EMA.
December 01, 2014
Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.
October 24, 2014
Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.
October 10, 2014
IDT Biologika completes large-scale biologics finishing facility in Dessau, Germany.
September 30, 2014
NIH seeks new therapeutic products to bolster the protective properties of vaccines.
September 23, 2014
CALIXAR and VirPath use new manufacturing techniques to create a vaccine for the pandemic flu, influenza A (H1N1), available in 2015.
September 19, 2014
Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.
September 05, 2014
FDA gives NewLink Genetics approval to proceed to Phase 1 clinical studies of Ebola vaccine.
July 30, 2014
Pfizer announced an agreement to acquire Baxter International?s marketed vaccines for $635 million.